Henning Glerup

ORCID: 0000-0002-8247-8766
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Vitamin D Research Studies
  • Microscopic Colitis
  • COVID-19 Clinical Research Studies
  • Vitamin C and Antioxidants Research
  • COVID-19 and healthcare impacts
  • Clostridium difficile and Clostridium perfringens research
  • Eosinophilic Esophagitis
  • Colorectal Cancer Screening and Detection
  • Spondyloarthritis Studies and Treatments
  • Bone health and osteoporosis research
  • Gut microbiota and health
  • Nutrition, Genetics, and Disease
  • Bone health and treatments
  • Global Cancer Incidence and Screening
  • Appendicitis Diagnosis and Management
  • Psoriasis: Treatment and Pathogenesis
  • Economic and Financial Impacts of Cancer
  • Rheumatoid Arthritis Research and Therapies
  • Helicobacter pylori-related gastroenterology studies
  • Dermatology and Skin Diseases
  • Monoclonal and Polyclonal Antibodies Research
  • Liver Disease Diagnosis and Treatment
  • Bone Tissue Engineering Materials
  • Multiple Myeloma Research and Treatments

Regionshospitalet Silkeborg
2012-2024

Aarhus University
1997-2022

Lillebaelt Hospital
2022

Aarhus University Hospital
1995-2016

University of Copenhagen
2007

Lund University
2007

Bandim Health Project
2007

Aarhus Municipality
2004

Regional Hospital Horsens
1994

Sunlight exposure of the skin is known to be most important source vitamin D. The aims this study were: (i) estimate D status amongst sunlight-deprived individuals (veiled Arab women, veiled ethnic Danish Moslem women and controls); (ii) through food intake analysis oral necessary keep a normal in individuals.Cross-sectional randomly selected origin living Denmark. Age-matched were included as controls. To control for racial differences, group (all Caucasians) was included.Primary Health...

10.1046/j.1365-2796.2000.00595.x article EN Journal of Internal Medicine 2000-02-01

Vitamin D has been shown to be involved in the host immune response toward Mycobacterium tuberculosis.To test whether vitamin supplementation of patients with tuberculosis (TB) improved clinical outcome and reduced mortality.We conducted a randomized, double-blind, placebo-controlled trial TB clinics at demographic surveillance site Guinea-Bissau. We included 365 adult starting antituberculosis treatment; 281 completed 12-month follow-up. The intervention was 100,000 IU cholecalciferol or...

10.1164/rccm.200804-567oc article EN American Journal of Respiratory and Critical Care Medicine 2009-01-30

Vitamin D has immune-regulatory functions in experimental colitis, and low vitamin levels are present Crohn's disease.To assess the effectiveness of D3 treatment disease with regard to improved course.We performed a randomized double-blind placebo-controlled trial benefits oral disease. We included 108 patients remission, which fourteen were excluded later. Patients receive either 1200 IU (n = 46) or placebo 48) once daily during 12 months. The primary endpoint was clinical relapse.Oral...

10.1111/j.1365-2036.2010.04355.x article EN Alimentary Pharmacology & Therapeutics 2010-05-11
Silvio Danese Séverine Vermeire Geert R. DʼHaens Julián Panés Axel Dignaß and 95 more Fernando Magro Maciej Nazar Manuela Le Bars Marjolein Lahaye Lioudmila Ni Ivana Bravatà F. Lavie Marco Daperno Milan Lukáš Alessandro Armuzzi Mark Löwenberg Daniel R. Gaya Laurent Peyrin‐Biroulet Rodolfo Rocca Susana Lopes Flavio Caprioli Sandro Ardizzone Ana Echarri Paolo Gionchetti Xavier Roblin Ursula Seidler David Andersson Kamal Patel Pierre Desreumaux Simone Saibeni Gustav From Miroslav Fedurco Miloš Greguš Yoram Bouhnik Andreas Luegering R. Cosintino Ivan Bunganič Jaime A. Ramos Mariam Aguas Peris Olivier Dewit Mariabeatrice Principi Emma Wesley Paula Lago Stéphane Nancey María Dolores Martín‐Arranz P. Hindryckx Ambrogio Orlando Andrea Geccherle Maria Laura Annunziata Bu Hayee Jozef Baláž Francisco Portela Cyrielle Gilletta Torsten Kucharzik Miguel Mínguez Javier P. Gisbert Ana Gutiérrez Édouard Louis Marco Marino Gareth M. B. Parkes Fraser Cummings Bindia Jharap Jens Kjeldsen L Correia Paula Ministro Matthias Ebert Erik Hertervig Dirk Staessen Joris Dutré A Colard Graham Morrison Henning Glerup Jens Frederik Dahlerup Frank H.J. Wolfhagen M Bátovský Martin Molnar Barbora Kadleckova Paulo Caldeira David Laharie Xavier Hébuterne Bruno Bonaz Matthieu Allez Andreas Fischer Joaquín Ernesto Hinojosa Del Val M Mañosa Círia José Manuel Herrera Justiniano Charlotte Söderman Rajiv Chandy Craig Mowat Peter M. Irving Jan Fallingborg Jan Matouš Tomáš Douda Romain Altwegg J M Benítez M Arroyo Jordi Guardiola Daniel Ginard Vicenc Pieter Dewint Sven Almér

10.1016/s2468-1253(21)00474-x article EN ˜The œLancet. Gastroenterology & hepatology 2022-02-02

BackgroundThe etiology of the inflammatory bowel diseases, including ulcerative colitis (UC), remains incompletely explained. We hypothesized that an analysis UC colon proteome could reveal novel insights into disease etiology.

10.1097/mib.0000000000000460 article EN cc-by-nc-nd Inflammatory Bowel Diseases 2015-05-20

Increased small intestinal wall thickness correlates with both inflammatory activity and fibrosis in Crohn’s disease [CD]. Assessment of perfusion holds promise as an objective marker distinguishing between the two conditions. Our primary aim was to determine if relative bowel measurements correlate histopathological scores for inflammation or CD. A total 25 patients were investigated before elective surgery Unenhanced ultrasonography [US] magnetic resonance enterography [MRE] applied...

10.1093/ecco-jcc/jjx111 article EN Journal of Crohn s and Colitis 2017-08-01

Evidence on ustekinumab safety in pregnancy is gradually expanding, but its clearance the postnatal period unknown. The aim of this study was to investigate concentrations umbilical cord blood and rates after birth, as well how these correlate with maternal drug concentrations, risk infection, developmental milestones during first year life.

10.1016/j.cgh.2024.01.008 article EN cc-by Clinical Gastroenterology and Hepatology 2024-01-01

We aimed at studying fracture risk in patients with Duchenne's muscular dystrophy (DMD), Becker's (BEMD), and spinal atrophy type II III (SMA III). A self-administered questionnaire was mailed to 293 DMD, BEMD, SMA or of which 229 returned the questionnaire. Each respondent compared an age- gender-matched control subject. The mean age 23.9 +/- 15.9 years for 23.3 16.5 controls. There were significantly more fractures among than controls after diagnosis made (RR = 1.9), but not before. had...

10.1080/16501970119066 article EN Journal of Rehabilitation Medicine 2001-07-02

Saccharomyces cerevisiae, known as baker's yeast, is normally considered a non-pathogenic yeast. A genetically very similar subtype, S boulardii, used in probioticum (Sacchaflor) to prevent antibiotic-associated diarrhoea and the treatment of recurrent Clostridium difficile associated diarrhoea. The authors present case report 79-year-old woman with rheumatoid arthritis, who after bowel resection developed boulardii fungemia. Her postoperative course was complicated by nutritional problems,...

10.1136/bcr.06.2011.4412 article EN BMJ Case Reports 2012-03-27

Rheumatoid arthritis (RA) is an inflammatory joint disease leading to cartilage damage and ultimately impaired function. To gain new insight into the systemic immune manifestations of RA, we characterized colon mucosa proteome from 11 RA-patients 10 healthy controls. The biopsies were extracted by colonoscopy analyzed label-free quantitative proteomics, enabling quantitation 5366 proteins. abundance dihydrofolate reductase (DHFR) was statistically significantly increased in RA-patient...

10.1021/acs.jproteome.6b00598 article EN Journal of Proteome Research 2016-09-14

An unbalanced intestinal microbiota may mediate activation of the inflammatory pathways seen in psoriatic arthritis (PsA). A randomised, placebo-controlled trial faecal transplantation (FMT) infused into small intestine patients with PsA active peripheral disease who are non-responsive to methotrexate (MTX) treatment will be conducted. The objective is explore clinical aspects associated FMT performed PsA.This a two-centre stratified, double-blind (patient, care provider and outcome...

10.1136/bmjopen-2017-019231 article EN cc-by-nc BMJ Open 2018-04-01

Abstract: In order to evaluate the use of recently developed assays bone metabolism in multiple myeloma we performed a histomorphometric study biopsies 16 patients. Furthermore, measured levels interleukin‐6 (IL‐6), soluble IL‐6 receptor (IL‐6sR), IL‐1β, tumour necrosis factor (TNF) α, TNFβ, and transforming growth (TGF) β marrow plasma aspirated from biopsy area. Markers resorption : The N ‐terminal telopeptide collagen I (Ntx) urine showed strong positive correlation with dynamic indices (...

10.1034/j.1600-0609.2000.90074.x article EN European Journal Of Haematology 2000-02-01

Survivor analysis of total hip replacement recently has shown disappointing results in younger patients. To improve this, ceramic coatings have been applied to prostheses for cementless use. A new fluorine containing coating, fluorapatite, increase bone ingrowth compared with hydroxyapatite unloaded models. In a weight loaded model, the effects and fluorapatite coated implants on implant fixation were evaluated. Eight porous surface inserted into medial femoral condyles 8 mature dogs paired...

10.1097/00003086-199703000-00037 article EN Clinical Orthopaedics and Related Research 1997-03-01
Séverine Vermeire Péter L. Lakatos Timothy E. Ritter Stephen B. Hanauer Brian Bressler and 95 more Reena Khanna Kim L. Isaacs Saumin Shah Alysha Kadva Helen E.J. Tyrrell Young S. Oh Swati Tole Akiko Chai Jennifer Pulley Christopher Eden Wenhui Zhang Brian G. Feagan Philip Abraham Mauro Acir Crippa Júnior Humberto Aguilar Tasneem Ahmed I Altorjay Vibeke Andersen Ronen Arai Hays Arnold Karlee Ausk Jeffrey Axler Kamran Ayub Avinash Balekuduru Guerino Barbalaco Neto Isaac Bassan Brian W. Behm Pradeep Bekal Shobna Bhatia Barnabás Bod Carlos Eduardo Brandão‐Mello Julia Brandeburova Johannes Breedt Brian Bressler Ivan V. Chopey Michael Connor Richard Corlin Carlos Alejandro Cortez Hernandez Arijit De Alexander de Sá Rolim Sandra Di Felice Boratto Tyler Dixon D. Poli D Dresner George Aaron Du Vall Matthias Ebert Robert Ehehalt Atilla Ertan R Valencia Jason Etzel Jan Fallingborg Brian G. Feagan Miroslav Fedurco Enrique Castro Valéria Ferreira de Almeida e Borges Mark Finklestein Andreas Fischer Mark R. Fleisher Angel Ricardo Flores Rendon Ronald Fogel Osvaldo Franceschi Curtis Freedland David Gatof Kanwar R. Gill Henning Glerup Vardaraj Gokak Eran Goldin Hector Alejandro Gomez Jaramillo Nitin Gupta Z Gurzó Olga Gyrina Mohammed Aejaz Habeeb Stephen Hanauer Robert Hardi William R. Harlan Ammar Hemaidan Melvin Heyman Péter Hoffmann William Holderman Frank Holtkamp-Endemann Gyula Horvat Kim L. Isaacs Eran Israeli Sender Jankiel Miszputen Søren Kejser Jensen Kenneth P. Johnson Jennifer Jones Osvaldo Da Silva Júnior Barbora Kadleckova Mukesh Kalla Zsuzsanna Kallo N C Karyotakis Lior H. Katz Leo Katz Nirmal Kaur

10.1016/s2468-1253(21)00295-8 article EN ˜The œLancet. Gastroenterology & hepatology 2021-11-17

INTRODUCTION: Magnetic resonance enterography (MRE) is useful for detecting bowel strictures, whereas a number of imaging biomarkers may reflect severity fibrosis burden in Crohn's disease (CD). This study aimed to verify the association MRE metrics with histologic independent inflammation. METHODS: prospective European multicenter performed on 60 patients CD strictures before surgical resection. Locations 61 histological samples were annotated examinations, followed by central readings...

10.14309/ctg.0000000000000505 article EN cc-by-nc-nd Clinical and Translational Gastroenterology 2022-06-13

Objective: Intestinal inflammation is frequent in patients with spondyloarthritis (SpA). Here, we test the validity of faecal calprotectin as a marker intestinal SpA and evaluate response adalimumab without lesions.Method: Patients were included on basis active Bath Ankylosing Spondylitis Disease Activity Index ≥ 4. After 4 week non-steroidal anti-inflammatory drug washout period, divided into two groups based level (> 100 mg/kg, n = 15, < 50 15). Adalimumab 40 mg every other was initiated....

10.1080/03009742.2017.1299216 article EN Scandinavian Journal of Rheumatology 2017-06-26

Abstract: This study was performed as a cross‐sectional substudy to the Danish–Swedish Pamidronate Study, randomized placebo‐controlled multicentre trial in multiple myeloma. The purpose evaluate biological effects of long‐term treatment with oral pamidronate 300 mg daily on bone metabolism by using histomorphometry and analysis cytokines biochemical markers turnover. Sixteen patients were included after median 27.5 months protocolized treatment; 10 received active 6 placebo. When compared...

10.1111/j.1600-0609.1998.tb01073.x article EN European Journal Of Haematology 1998-08-01

A better understanding of the clinical relevance delayed gastric emptying (e.g. in diabetes) requires a simple, easily accessible and inexpensive method for measuring it. Two "new" methods liquids (the paracetamol absorption test 13C-acetate breath test) are compared with gold standard (gastric scintigraphy (GES)).The three techniques were used simultaneously 10 healthy subjects. time-retention curve was drawn each technique results at 75%, 50% 25% retention quartiles.Agreement found between...

10.1080/00365520701370922 article EN Scandinavian Journal of Gastroenterology 2007-01-01

Chronic inflammatory diseases (CIDs), including Crohn’s disease and ulcerative colitis (inflammatory bowel diseases, IBD), rheumatoid arthritis, psoriasis, psoriatic spondyloarthritides, hidradenitis suppurativa, immune-mediated uveitis, are treated with biologics targeting the pro-inflammatory molecule tumour necrosis factor-α (TNF) (i.e., TNF inhibitors). Approximately one-third of patients do not respond to treatment. Genetics lifestyle may affect treatment results. The aims this...

10.3390/nu9050499 article EN Nutrients 2017-05-15

Introduction Chronic inflammatory diseases (CIDs) are frequently treated with biological medications, specifically tumour necrosis factor inhibitors (TNFi)). These medications inhibit the pro-inflammatory molecule TNF alpha, which has been strongly implicated in aetiology of these diseases. Up to one-third patients do not, however, respond biologics, and lifestyle factors assumed affect treatment outcomes. Little is known about effects dietary as a prognostic that may enable personalised...

10.1136/bmjopen-2017-018166 article EN cc-by-nc BMJ Open 2018-02-01
Coming Soon ...